AstraZeneca Financial Statements From 2010 to 2026

AstraZeneca PLC Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 125.6 B 119.6 B 73.8 B Slightly volatile Short and Long Term Debt Total 36.4 B 34.6 B 20.1 B Slightly volatile Total Current Liabilities 33.6 B 32 B 19.9 B Slightly volatile Total Stockholder Equity 49.2 B 46.9 B 25.4 B Slightly volatile Property Plant And Equipment Net 7 B 13.4 B 7.9 B Slightly volatile Net Debt 29.7 B 28.3 B 14.2 B Slightly volatile Accounts Payable 2.9 B 4.2 B 3 B Pretty Stable Cash 4.5 B 6.3 B 5.8 B Very volatile Non Current Assets Total 94.4 B 89.9 B 53.9 B Slightly volatile Cash And Short Term Investments 5.8 B 6.4 B 6.6 B Pretty Stable Common Stock Shares Outstanding 2.8 B 3.6 B 2.6 B Slightly volatile Short Term Investments 31.6 M 33.3 M 705.8 M Slightly volatile Liabilities And Stockholders Equity 125.6 B 119.6 B 73.8 B Slightly volatile Non Current Liabilities Total 42.6 B 40.6 B 28 B Slightly volatile Inventory 6.4 B 6.1 B 3.7 B Slightly volatile Other Current Assets 4 B 4.3 B 3.3 B Very volatile Total Liabilities 76.3 B 72.6 B 47.9 B Slightly volatile Total Current Assets 15.7 B 29.7 B 18.9 B Slightly volatile Short Term Debt 1.5 B 2.9 B 2.3 B Slightly volatile Other Assets 5 B 4.8 B 3.1 B Slightly volatile Capital Stock 297.7 M 349.2 M 332.8 M Slightly volatile Common Stock 297.7 M 349.2 M 332.8 M Slightly volatile Other Liabilities 6.7 B 9.8 B 8.9 B Slightly volatile Long Term Debt 32 B 30.5 B 17.2 B Slightly volatile Good Will 25.4 B 24.2 B 14.3 B Slightly volatile Property Plant Equipment 7.9 B 10.9 B 7.8 B Slightly volatile Common Stock Total Equity 280.8 M 295.2 M 323.8 M Slightly volatile Property Plant And Equipment Gross 8.9 B 13.4 B 8.8 B Slightly volatile Noncontrolling Interest In Consolidated Entity 19.7 M 20.7 M 435.1 M Pretty Stable Additional Paid In Capital 42.7 B 40.6 B 16.4 B Slightly volatile Long Term Investments 970 M 1.7 B 1 B Slightly volatile Short and Long Term Debt 2.4 B 1.9 B 4.2 B Slightly volatile Deferred Long Term Liabilities 3.1 B 4.5 B 3.2 B Slightly volatile Long Term Debt Total 17.1 B 18.6 B 15.6 B Slightly volatile Capital Surpluse 5.6 B 9.1 B 6 B Slightly volatile Net Invested Capital 55.1 B 79.9 B 45 B Slightly volatile
AstraZeneca PLC Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 6.1 B 5.8 B 3.7 B Slightly volatile Interest Expense 2 B 1.9 B 1.2 B Slightly volatile Total Revenue 65.3 B 62.2 B 33.7 B Slightly volatile Gross Profit 53 B 50.4 B 26.8 B Slightly volatile Other Operating Expenses 53.2 B 50.7 B 27.9 B Slightly volatile Operating Income 12.1 B 11.5 B 5.8 B Slightly volatile EBIT 12.5 B 11.9 B 5.9 B Slightly volatile Research Development 16.4 B 15.6 B 7.9 B Slightly volatile EBITDA 18.6 B 17.8 B 9.6 B Slightly volatile Total Operating Expenses 40.9 B 38.9 B 21 B Slightly volatile Net Income 8.5 B 8.1 B 4.1 B Slightly volatile Selling General Administrative 11.6 B 22.6 B 12.7 B Slightly volatile Cost Of Revenue 6.4 B 11.7 B 6.7 B Slightly volatile Net Income Applicable To Common Shares 3.2 B 3 B 3.2 B Slightly volatile Selling And Marketing Expenses 474.5 M 499.5 M 3.5 B Pretty Stable Net Income From Continuing Ops 8.5 B 8.1 B 3.5 B Slightly volatile Interest Income 345.1 M 412.2 M 415.4 M Pretty Stable Reconciled Depreciation 5.1 B 7.7 B 4.2 B Slightly volatile Extraordinary Items 492.8 M 554.4 M 605.1 M Slightly volatile
AstraZeneca PLC Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 8.8 B 8.4 B 4.1 B Slightly volatile Begin Period Cash Flow 4.5 B 6.5 B 6 B Pretty Stable Depreciation 6.1 B 5.8 B 3.9 B Slightly volatile Capital Expenditures 5.5 B 5.3 B 2.8 B Slightly volatile Total Cash From Operating Activities 14.3 B 13.6 B 6.9 B Slightly volatile End Period Cash Flow 4.2 B 6.2 B 5.6 B Very volatile Stock Based Compensation 340.4 M 665.9 M 328 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 4.19 4.41 10.3085 Slightly volatile Dividend Yield 0.0221 0.0205 0.033 Slightly volatile PTB Ratio 5.44 5.72 91.1906 Slightly volatile Days Sales Outstanding 98.53 104 92.2503 Slightly volatile Book Value Per Share 24.92 23.73 17.5415 Slightly volatile Free Cash Flow Yield 0.0277 0.0323 0.0315 Pretty Stable Operating Cash Flow Per Share 7.23 6.89 4.68 Slightly volatile Average Payables 1.3 B 2.4 B 2.5 B Very volatile Stock Based Compensation To Revenue 0.0101 0.0112 0.0113 Slightly volatile Capex To Depreciation 1.31 1.04 0.8584 Pretty Stable PB Ratio 5.44 5.72 91.1906 Slightly volatile EV To Sales 4.7 4.94 10.7333 Slightly volatile Free Cash Flow Per Share 4.44 4.22 2.7084 Slightly volatile Inventory Turnover 2.93 2.88 2.6 Pretty Stable Net Income Per Share 4.2 4.0 2.7578 Very volatile Days Of Inventory On Hand 164 167 155 Slightly volatile Payables Turnover 2.1 3.27 3.0331 Slightly volatile Sales General And Administrative To Revenue 0.28 0.33 0.3552 Slightly volatile Average Inventory 1.4 B 1.4 B 1.2 B Slightly volatile Research And Ddevelopement To Revenue 0.14 0.2 0.1975 Slightly volatile Capex To Revenue 0.0637 0.078 0.0846 Slightly volatile Cash Per Share 3.05 3.28 4.6808 Slightly volatile POCF Ratio 18.7 19.68 80.9695 Slightly volatile Interest Coverage 10.04 10.57 9.1595 Slightly volatile Payout Ratio 0.57 0.6 3.1354 Pretty Stable Capex To Operating Cash Flow 0.68 0.44 0.4951 Very volatile PFCF Ratio 30.49 32.09 238 Slightly volatile Days Payables Outstanding 202 115 155 Slightly volatile ROE 0.33 0.19 0.2116 Slightly volatile EV To Operating Cash Flow 20.97 22.07 83.5044 Slightly volatile PE Ratio 32.2 33.89 238 Pretty Stable Return On Tangible Assets 0.11 0.14 0.1152 Pretty Stable EV To Free Cash Flow 34.18 35.98 244 Slightly volatile Earnings Yield 0.0342 0.0305 0.0367 Slightly volatile Intangibles To Total Assets 0.26 0.5 0.4923 Slightly volatile Net Debt To EBITDA 0.81 1.49 1.7932 Slightly volatile Current Ratio 1.5 1.06 1.1247 Slightly volatile Receivables Turnover 4.68 4.65 4.1608 Slightly volatile Graham Number 48.47 46.16 30.6844 Slightly volatile Shareholders Equity Per Share 24.87 23.68 17.1982 Slightly volatile Debt To Equity 0.81 0.85 1.1753 Slightly volatile Capex Per Share 2.8 2.66 1.9716 Slightly volatile Average Receivables 1.7 B 3 B 3.1 B Very volatile Revenue Per Share 32.28 30.74 23.0539 Slightly volatile Interest Debt Per Share 19.19 18.28 14.3428 Slightly volatile Debt To Assets 0.17 0.26 0.2719 Pretty Stable Enterprise Value Over EBITDA 16.74 17.62 53.1024 Slightly volatile Short Term Coverage Ratios 12.08 6.33 3.9951 Pretty Stable Price Earnings Ratio 32.2 33.89 238 Pretty Stable Operating Cycle 158 212 225 Pretty Stable Price Book Value Ratio 5.44 5.72 91.1906 Slightly volatile Days Of Payables Outstanding 202 115 155 Slightly volatile Dividend Payout Ratio 0.57 0.6 3.1354 Pretty Stable Price To Operating Cash Flows Ratio 18.7 19.68 80.9695 Slightly volatile Price To Free Cash Flows Ratio 30.49 32.09 238 Slightly volatile Operating Profit Margin 0.16 0.21 0.1788 Slightly volatile Company Equity Multiplier 5.68 2.93 3.8319 Pretty Stable Long Term Debt To Capitalization 0.25 0.35 0.423 Pretty Stable Total Debt To Capitalization 0.28 0.38 0.4572 Pretty Stable Return On Capital Employed 0.24 0.19 0.1364 Pretty Stable Debt Equity Ratio 0.81 0.85 1.1753 Slightly volatile Ebit Per Revenue 0.16 0.21 0.1788 Slightly volatile Quick Ratio 1.19 0.85 0.9016 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.31 1.48 1.0476 Very volatile Cash Ratio 0.25 0.18 0.3072 Slightly volatile Operating Cash Flow Sales Ratio 0.14 0.2 0.189 Pretty Stable Days Of Inventory Outstanding 164 167 155 Slightly volatile Days Of Sales Outstanding 98.53 104 92.2503 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.3 0.55 0.5031 Very volatile Cash Flow Coverage Ratios 0.43 0.45 0.3812 Slightly volatile Price To Book Ratio 5.44 5.72 91.1906 Slightly volatile Fixed Asset Turnover 2.75 4.09 3.8072 Pretty Stable Capital Expenditure Coverage Ratio 2.24 2.33 2.4563 Very volatile Price Cash Flow Ratio 18.7 19.68 80.9695 Slightly volatile Enterprise Value Multiple 16.74 17.62 53.1024 Slightly volatile Debt Ratio 0.17 0.26 0.2719 Pretty Stable Cash Flow To Debt Ratio 0.43 0.45 0.3812 Slightly volatile Price Sales Ratio 4.19 4.41 10.3085 Slightly volatile Return On Assets 0.1 0.0761 0.0605 Pretty Stable Asset Turnover 0.78 0.59 0.5121 Pretty Stable Net Profit Margin 0.1 0.12 0.1147 Slightly volatile Gross Profit Margin 0.83 0.86 0.7441 Very volatile Price Fair Value 5.44 5.72 91.1906 Slightly volatile Return On Equity 0.33 0.19 0.2116 Slightly volatile
AstraZeneca PLC Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 253.6 B 242.4 B 176.7 B Very volatile Enterprise Value 268.5 B 268.4 B 190 B Very volatile

AstraZeneca Fundamental Market Drivers

AstraZeneca Upcoming Events

About AstraZeneca PLC Financial Statements

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:

How To Invest In AstraZeneca Details

Is AstraZeneca Stock a good investment? Details

What is AstraZeneca PLC's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details